Compare CSWC & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSWC | ATRC |
|---|---|---|
| Founded | 1961 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 1994 | 2005 |
| Metric | CSWC | ATRC |
|---|---|---|
| Price | $25.47 | $48.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $23.50 | ★ $51.17 |
| AVG Volume (30 Days) | 588.2K | ★ 731.6K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | ★ 10.89% | N/A |
| EPS Growth | 29.25 | ★ 74.74 |
| EPS | ★ 0.39 | 0.18 |
| Revenue | $10,835,000.00 | ★ $201,630,000.00 |
| Revenue This Year | $17.45 | $15.27 |
| Revenue Next Year | $10.26 | $12.21 |
| P/E Ratio | ★ $65.13 | $273.72 |
| Revenue Growth | ★ 16.08 | 15.40 |
| 52 Week Low | $19.37 | $25.36 |
| 52 Week High | $25.48 | $49.88 |
| Indicator | CSWC | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 70.24 | 77.36 |
| Support Level | $22.76 | $26.47 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.27 | 1.64 |
| MACD | 0.04 | 0.09 |
| Stochastic Oscillator | 99.58 | 89.80 |
Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source of revenue comprises interest income and dividend income from investments made as well as management fees.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.